Internal Medicine, Endocrinology, Diabetes, & Metabolism · Modesto, CA
NPI
1306096698
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
4601 Dale Rd
Modesto, CA, 95356
Phone (209) 470-2896
Groups this clinician bills Medicare through
Medicare paid, 2024
$42K
524 services
Medicare patients, 2024
238
Average age 72
Drug cost, 2024
$1.2M
2,795 prescriptions
Company payments, 2025
$6,030
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amit Bhargava was code 99214 (office e&m - established), 296 times for 161 patients. In total Amit Bhargava billed 524 services in 15 codes, and Medicare paid $42K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 296 | 161 | $89.59 | $27K |
| 99232 Hospital E&M - Subsequent | Facility | 100 | 40 | $60.39 | $6,039 |
| 95251 Test - Miscellaneous | Office | 38 | 28 | $26.38 | $1,002 |
| 99204 Office E&M - New | Office | 32 | 32 | $114.54 | $3,665 |
| 99222 Hospital E&M - Initial | Facility | 29 | 29 | $102.10 | $2,961 |
By year: 2022 $39K for 475 services; 2023 $42K for 530 services; 2024 $42K for 524 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amit Bhargava prescribed most often to Medicare patients was Levothyroxine Sodium, with 408 prescriptions and refills. In total Amit Bhargava wrote 2,795 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 408 | 1,060 | 117 | $4,828 |
| Trulicity Dulaglutide | 171 | 232 | 42 | $221K |
| Synthroid Levothyroxine Sodium | 158 | 407 | 44 | $10K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 149 | 422 | 69 | $21K |
| Methimazole Generic | 134 | 254 | 28 | $1,164 |
| Ozempic Semaglutide | 128 | 207 | 33 | $193K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 122 | 301 | 55 | $16K |
| Jardiance Empagliflozin | 107 | 176 | 28 | $101K |
| Metformin Hcl Generic | 105 | 293 | 41 | $726 |
| Metformin Hcl Er Metformin Hcl | 78 | 224 | 36 | $1,865 |
| Basaglar Kwikpen U-100 Insulin Glargine,hum.Rec.Anlog | 59 | 150 | 22 | $30K |
| Novolog Flexpen Insulin Aspart | 54 | 125 | 34 | $15K |
| Atorvastatin Calcium Generic | 52 | 150 | 18 | $365 |
| Humalog Kwikpen U-100 Insulin Lispro | 47 | 114 | 23 | $19K |
| Novolog Insulin Aspart | 45 | 77 | 13 | $16K |
Brand drugs: 1,406 claims; generic drugs: 1,094 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amit Bhargava $6,030 ($6,030 in general payments such as food, travel and fees) from 5 companies. The largest payer was Medtronic, Inc. with $5,838.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.